Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 49.70
-0.20 (-0.40%)
Jun 24, 2026, 4:25 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 222.58 million as of June 24, 2026.
Market Cap
222.58M
Enterprise Value
48.52M
Revenue
28.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.70
Market Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 222.58M, an increase of 19.41%. That is a compound annual growth rate of 31.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 222.58M | 1.22% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.95B |
| Thor Medical ASA | 1.53B |
| Nykode Therapeutics AS | 1.05B |
| ArcticZymes Technologies ASA | 1.03B |
| Lytix Biopharma ASA | 715.17M |
| Zelluna ASA | 558.86M |
| SoftOx Solutions AS | 281.10M |
| Arctic Bioscience AS | 88.96M |